Oklahoma Senate Bill SB1329

Oklahoma 2026 Regular Session

• Introduced: 2/2/26
• Refer: 2/3/26
• Report Pass: 2/9/26
• Refer: 2/9/26

Caption

Medicaid; requiring Medicaid providers to conduct certain screening; providing for reimbursement. Effective date.

Summary

SB1329 creates a new Medicaid-related requirement for postpartum care. It defines the “postpartum period” as the year following childbirth and requires any health care provider participating in the state Medicaid program who sees a Medicaid member or her infant during that period to conduct a mental health screening of the mother for signs of postpartum depression. The bill also makes the screening reimbursable under Medicaid, directs the Oklahoma Health Care Authority to seek any necessary federal approval, and requires the agency’s board to adopt rules to implement the new law. The measure is scheduled to take effect November 1, 2026.

Impact

If enacted, SB1329 would add a specific postpartum depression screening obligation to Oklahoma’s Medicaid program and create a corresponding reimbursement pathway for providers. It would affect Medicaid-participating physicians and other health care providers who see postpartum women or their infants, as well as the Oklahoma Health Care Authority, which would need to pursue federal approval and promulgate implementing rules. The bill would be codified in Title 63 of the Oklahoma Statutes as a new section governing postpartum screening within Medicaid.

Sentiment

The available legislative history suggests generally favorable sentiment toward the bill. It passed the Senate Health and Human Services Committee by a 10-1 vote, indicating broad support for expanding postpartum mental health screening and Medicaid reimbursement. No committee transcript is available, so the record does not show detailed debate, but the strong committee vote suggests the measure was viewed as a public health and maternal care improvement.

Contention

The main potential points of contention are administrative and fiscal rather than policy-based. The bill requires Medicaid providers to perform screenings and the state agency to secure federal approval and adopt rules, which could raise concerns about implementation burden, provider compliance, and Medicaid costs. The lone committee dissent suggests at least one member had reservations, but the available record does not identify the specific objection or whether it related to cost, mandate scope, or federal approval requirements.